Evolveimmune Therapeutics Inc. has announced a translational research collaboration with Memorial Sloan Kettering Cancer Center (MSK) to investigate the expression of a new tumor target – UL binding ...

Researchers have created a "metal detector" algorithm called PRRDetect to hunt down vulnerable tumors, in a development that ...

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

A new USC-led study using functional magnetic resonance imaging (fMRI) reveals the neural mechanisms that contribute to ...

The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...

WASHINGTON, DC – The United States Supreme Court has denied a final plea by Tahawwur Rana—accused of aiding the 2008 Mumbai ...

In a groundbreaking leap for cancer treatment, Cambridge researchers have unveiled a sophisticated new algorithm that may transform how vulnerable tumors are identified and treated. Dubbed PRRDetect, ...

The FDA cleared the firm this week to begin a Phase I study of ALX2004 in EGFR-expressing solid tumors, which could start in a few months.

PRRDetect, which was developed by researchers at the University of Cambridge, could one day be used to identify which cancer ...

Study finds enfortumab vedotin + pembrolizumab significantly boosts survival in advanced urothelial carcinoma patients ...

A mom shared footage on TikTok showing the rare symptom that hinted at the heartbreaking diagnosis that was to come. In ...